Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with peripheral artery disease (poor blood flow in the legs) that causes symptoms such as leg cramping when walking or pain at rest, but does not yet involve tissue death or gangrene (a specific level called Rutherford 2–4)
- The blocked or narrowed blood vessel being treated is located in a specific artery in your thigh (superficial femoral artery) or behind the knee (popliteal artery), or both, and has not previously had a stent placed there
Who may not be able to join:
- You are under 18 years of age
- You are unable or unwilling to give your consent to take part in the study
- Your doctor believes your life expectancy is 12 months or less
- You are pregnant, breastfeeding, planning to become pregnant within 12 months of the procedure, or unwilling to use contraception for 12 months after the procedure (a negative pregnancy test within 7 days before the procedure is also required if applicable)
- You are unable or unwilling to attend the required follow-up appointments after the procedure
- You are currently taking part in another clinical trial involving an experimental drug or device, unless it has been at least 30 days since the main measurement point of that previous study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eric Secemsky, MD, Beth Israel Deaconess Medical Center
Phone: 765-463-7537
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Primary safety endpoint; Primary effectiveness endpoint
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.